Vitamin B12, folate, and homocysteine levels in patients with obsessive–compulsive disorder

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 1671-1675

  Türksoy, Nuray ^a   Bilici, Rabia ^b   Yalçiner, Altan ^c   Özdemir, Y Özay ^b   Örnek, Ibrahim ^d   Tufan, Ali Evren ^e   Kara, Ayşe ^f  

^a Simurg Psychiatry and Psychotherapy center   (Turkey)

^b Research and Training Hospital for Neurologic and Psychiatric Diseases   (Turkey)

^c Duzen Laboratories   (Turkey)

^d FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

^e ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^f Bakirkoy Hospital for Psychiatric and Neurological Diseases   (Turkey)

Author keywords

Compulsion; Folate; Homocysteine; Obsession; Obsessive compulsive disorder; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN BLOOD LEVEL; CYANOCOBALAMIN DEFICIENCY; DISEASE DURATION; DISEASE MARKER; FEMALE; FOLIC ACID BLOOD LEVEL; HAMILTON SCALE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; VITAMIN BLOOD LEVEL; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84907195380     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S67668     Document Type: Article

References (27)

1. Fafouti M, Paparrigopoulos T, Liappas J, Mantouvalos V, Typaldou R, Christodoulou G. Mood disorder with mixed features due to vitamin B12 and folate defciency. Gen Hosp Psychiatry. 2002;24(2):106–109.
2. Stanger O, Fowler B, Piertzik K, et al. Homocysteine, folate, and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother. 2009;9(9):1393–1412.
3. Kale A, Naphade N, Sapkale S, et al. Reduced folic acid, vitamin B12, and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 2010;175(1–2):47–53.
4. Kim TH, Moon S W. Serum homocysteine and folate levels in Korean schizophrenic patients. Psychiatry Investig. 2011;8(2):134–140.
5. Ezzaher A, Mouhamed DH, Mechri A, et al. Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry Clin Neurosci. 2011;65(7): 664–671.
6. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1997;54(12):382–390.
7. Coppen A, Swade C, Jones SA, Armstrong RA, Blair JA, Leeming RJ. Depression and tetrahydrobiopterin: the folate connection. J Affect Disord. 1989;16(2–3):103–107.
8. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000;69(2): 228–232.
9. Sachdev PS, Parslow RA, Lux O, et al. Relationship of homocysteine, folic acid, and vitamin B12 with depression in a middle-aged community sample. Psychol Med. 2005;35(4):529–538.
10. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Predictive value of folate, vitamin B12, and homocysteine levels in late-life depression. Br J Psychiatry. 2008;192(4):268–274.
11. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate defciency detected by capillary gas chroma-tography-mass spectrometry. J Clin Invest. 1988;81(2):466–474.
12. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin defciency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318(26):1720–1728.
13. Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M. Folinic acid (leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry. 2002;14(1):33–38.
14. Başoğlu C, Alpay Ateş M, Algül A, et al. Adjuvant folate with escitalo-pram treatment and homocysteine, folate, vitamin B12 levels in patients with major depressive disorder. Bulletin of Clinical Psychopharmacology. 2009;19(2):135–142.
15. Hermesh H, Weizman A, Shahar A, Munitz H. Vitamin B12 and folic acid serum levels in obsessive compulsive disorder. Acta Psychiatr Scand. 1988;78(1):8–10.
16. Atmaca M, Tezcan E, Kuloglu M, Kirtas O, Ustandag B. Serum folate and homocysteine levels in patients with obsessive–compulsive disorder. Psychiatry Clin Neurosci. 2005;59(5):616–620.
17. Levine J, Timinsky I, Vishne T, et al. Elevated serum homocysteine levels in male patients with PTSD. Depress Anxiety. 2008;25(11): E154–E157.
18. Sharma V, Biswas D. Cobalamin defciency presenting as obsessive compulsive disorder: case report. Gen Hosp Psychiatry. 2012; 34(5):e7–e8.
19. Fireman B, Koran LM, Leventhal JL, Jacobson A. The prevalence of clinically recognized obsessive–compulsive disorder in a large health maintenance organization. Am J Psychiatry. 2001;158(11): 1904–1910.
20. Tükel R, Polat A, Özdemir Ö, Aksüt D, Türksoy N. Comorbid conditions in obsessive–compulsive disorder. Compr Psychiatry. 2002;43(3): 204–209.
21. Türksoy N, Tükel R, Özdemir Ö, Karali A. Comparison of clinical characteristics in good and poor insight obsessive–compulsive disorder. J Anxiety Disord. 2002;16(4):413–423.
22. Gururaj GP, Math SB, Reddy JY, Chandrashekar CR. Family burden, quality of life, and disability in obsessive compulsive disorder: an Indian perspective. J Postgrad Med. 2008;54(2):91–97.
23. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R, Non-patient Edition (SCID-NP). Washington, DC: American Psychiatric Press; 1990.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press; 1996.
25. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychology. 1967;6(4):278–296.
26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55.
27. Goodman WK, Price LH, Rasmussen SA, et al. The Yale–Brown Obsessive–Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–1011.